Lipid nanoparticles for parenteral delivery of actives

被引：337

作者：

Joshi, Medha D. ^{[1
]}

Mueller, Rainer H. ^{[1
]}

机构：

[1] Free Univ Berlin, Dept Pharmaceut Technol Biopharmaceut & NutriCosm, D-12169 Berlin, Germany

来源：

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | 2009年 / 71卷 / 02期

关键词：

Lipid nanoparticles; Solid lipid nanoparticles (SLN); Nanostructured lipid carriers (NLC); Lipid drug conjugates (LDC); Parenteral delivery; PROTEIN ADSORPTION PATTERNS; 80-COATED POLYBUTYLCYANOACRYLATE NANOPARTICLES; BLOOD-BRAIN-BARRIER; BREAST-CANCER CELLS; TUMOR-BEARING MICE; IN-VITRO; TISSUE DISTRIBUTION; DRUG-DELIVERY; CYTOKINE PRODUCTION; PHARMACOKINETIC EVALUATION;

D O I：

10.1016/j.ejpb.2008.09.003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The present review compiles the applications of lipid nanoparticles mainly solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC) and lipid drug conjugates (LDC) in parenteral delivery of pharmaceutical actives. The attempts to incorporate anticancer agents, imaging agents, antiparasitics, antiarthritics, genes for transfection, agents for liver, cardiovascular and central nervous system targeting have been summarized. The utility of lipid nanoparticles as adjuvant has been discussed separately. A special focus of this review is on toxicity caused by these kinds of lipid nanoparticles with a glance on the fate of lipid nanoparticles after their parenteral delivery in vivo viz the protein adsorption patterns. (C) 2008 Elsevier B.V. All rights reserved.

引用

页码：161 / 172

页数：12

共 140 条

[91] Biodistribution of stealth and non-stealth solid lipid nanospheres after intravenous administration to rats [J].

Podio, V ;

Zara, GP ;

Carazzone, M ;

Cavalli, R ;

Gasco, MR .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 2000, 52 (09) :1057-1063

[92] Tamoxifen citrate loaded solid lipid nanoparticles SLN™):: Preparation, characterization, in vitro drug release, and pharmacokinetic evaluation [J].

Reddy, L. Harivardhan ;

Vivek, K. ;

Bakshi, Nishant ;

Murthy, R. S. R. .

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2006, 11 (02) :167-177

[93] Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice [J].

Reddy, LH ;

Sharma, RK ;

Chuttani, K ;

Mishra, AK ;

Murthy, RSR .

JOURNAL OF CONTROLLED RELEASE, 2005, 105 (03) :185-198

[94]

Reddy LH, 2004, AAPS J, V6

[95] SULFAMETHYLTHIADIAZOLE - HUMAN BLOOD CONCENTRATION AND URINARY EXCRETION DATA FOLLOWING ORAL DOSES [J].

ROBINSON, MJ ;

BONDI, A ;

SWINTOSKY, JV .

JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1958, 47 (12) :874-878

[96] Lipid nanoparticles for improved topical application of drugs for skin diseases [J].

Schaefer-Korting, Monika ;

Mehnert, Wolfgang ;

Korting, Hans-Christian .

ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (06) :427-443

[97]

SCHMITT J, 1998, PHARMAZEUTISCHE TECH, P189

[98] Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages [J].

Schöler, N ;

Hahn, H ;

Müller, RH ;

Liesenfeld, O .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 231 (02) :167-176

[99] Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages [J].

Schöler, N ;

Olbrich, C ;

Tabatt, K ;

Muller, RH ;

Hahn, H ;

Liesenfeld, O .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 221 (1-2) :57-67

[100] Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis [J].

Schöler, N ;

Krause, K ;

Kayser, O ;

Müller, RH ;

Borner, K ;

Hahn, H ;

Liesenfeld, O .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1771-1779

← 5 6 7 8 9 10 11 12 13 14 →